Companies similar to Gracure Pharmaceuticals for Business Development Executive
Company name | Avg Annual Salary | Open Jobs |
---|---|---|
![]() Boehringer-Ingelheim Business Development Executive Salary
5 - 8 years exp. (6 salaries) | ₹3.9 L/yr - ₹10 L/yr | |
![]() Aimil Pharmaceuticals Business Development Executive Salary
0 - 3 years exp. (6 salaries) | ₹2.9 L/yr - ₹3.7 L/yr | |
Login to view exact salary
| ||
![]() AstraZeneca Business Development Executive Salary
1 - 4 years exp. (4 salaries) | ₹2.1 L/yr - ₹3 L/yr | |
![]() Inventia Healthcare Business Development Executive Salary
1 - 5 years exp. (4 salaries) | ₹4 L/yr - ₹6.6 L/yr | |
![]() Virbac Animal Health Business Development Executive Salary
4 - 8 years exp. (4 salaries) | ₹2.9 L/yr - ₹7.2 L/yr | |
Experience wise Gracure Pharmaceuticals Business Development Executive salaries
Last Updated: 16 Jun 2024
Experience | Avg Annual Salary |
---|---|
Fresher (AmbitionBox Estimate) |
₹3.6
L/yr
- ₹4.6
L/yr
|
2 years (AmbitionBox Estimate) |
₹3.2
L/yr
- ₹4.1
L/yr
|
Login to view exact salary
| |
4 years (AmbitionBox Estimate) |
₹2.7
L/yr
- ₹3.5
L/yr
|
Similar Designation salaries in Gracure Pharmaceuticals
Top skills at Gracure Pharmaceuticals for Business Development Executive
Salary related reviews for Gracure Pharmaceuticals
Discover interview dos and don'ts from real experiences
Top trending discussions








Gracure Pharmaceuticals Business Development Executive Salary FAQs
Experience | Average Salary Range |
---|---|
Fresher | ₹3.6 Lakhs to ₹4.6 Lakhs per year |
2 years | ₹3.2 Lakhs to ₹4.1 Lakhs per year |
4 years | ₹2.7 Lakhs to ₹3.5 Lakhs per year |
Tell us how to improve this page.
- Home >
- Salaries >
- Gracure Pharmaceuticals Salaries >
- Gracure Pharmaceuticals Business Development Executive Salaries
Gracure Pharmaceuticals Business Development Executive salary
in
India
ranges between ₹3
Lakhs to ₹4
Lakhs with an average annual salary of
₹. Salary estimates are based on
3
Gracure Pharmaceuticals latest salaries received from various employees of
Gracure Pharmaceuticals.